Alliances and Partnerships

Working closely with leading biotechnology and pharmaceutical companies, we can accelerate product opportunities that will ultimately benefit patients and partners alike. Our capabilities in cellular biology, peptide and dialkylated amino acid chemistry, microbiology, bioinformatics, preclinical and clinical development, and regulatory affairs, and our strong IP position provide partners with the ability to rapidly move RNAi product candidates through the R&D process. All 20,000 human genes are available for development through our patent estate enabling us to pursue any disease target of our choosing without the need to obtain licenses to existing patents.